<DOC>
	<DOC>NCT01923389</DOC>
	<brief_summary>This is a trial in obese subjects to study the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of PF-05231023.</brief_summary>
	<brief_title>Multiple Dose Study Of PF-05231023 In Obese Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Male and female subjects of nonchildbearing potential between the ages of 21 and 70. Subjects with a BMI of 30 to 45.4 kg/m2 and total body weight &gt;110 lbs. Recent (6 months) unstable concurrent disease. History of allergic disease or drug allergies. Any condition affecting food consumption or absorption.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>T2DM</keyword>
	<keyword>obesity</keyword>
	<keyword>safety</keyword>
	<keyword>multiple dose</keyword>
	<keyword>intravenous</keyword>
</DOC>